Evidence map›Paper›PMID 31024443›Full record

ArticleFrontiers in endocrinology2019

Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients.

Danilo Villagelin, João Romaldini, Juliana Andrade, Roberto Santos, Ana Milkos, Patricia Fátima Dos Santos Teixeira, Laura S Ward

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Improvement of asymmetric thyroid eye disease with teprotumumab.The British journal of ophthalmology · 2022
    Trial
  3. Article
  4. Article
  5. A multifactorial screening model based on the Graves ophthalmopathy quality of life scores in dysthyroid optic neuropathy.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Danilo VillagelinEndocrinology and Metabolism, School of Medicine, Pontifical Catholic University of Campinas, Campinas, Brazil.
João RomaldiniEndocrinology and Metabolism, School of Medicine, Pontifical Catholic University of Campinas, Campinas, Brazil.
Juliana AndradeHospital do Servidor Público Estadual, São Paulo, Brazil.
Roberto SantosEndocrinology and Metabolism, School of Medicine, Pontifical Catholic University of Campinas, Campinas, Brazil.
Ana MilkosHospital do Servidor Público Estadual, São Paulo, Brazil.
Patricia Fátima Dos Santos TeixeiraEndocrinology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Laura S WardLaboratory of Cancer Molecular Genetics, School of Medicine Sciences, Campinas State University, Campinas, Brazil.
Hospital do Servidor Público Estadual · BRPontifícia Universidade Católica de São Paulo · BRPontifícia Universidade Católica de Campinas · BRUniversidade Estadual de Campinas (UNICAMP) · BRUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graves diseaseGraves orbitopathyhyperthyroidismquality of Lifethyroid

Identifiers

PMID31024443
PMCPMC6460048
OpenAlexW2927145326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.